Sinovac Biotech

SINOVAC科兴上市产品主要包括:新型冠状病毒灭活疫苗(克尔来福®)、预防用生物制品1类新药——肠道病毒71型灭活疫苗(益尔来福®)、中国第一支甲型肝炎灭活疫苗(孩尔来福®)、三价流感病毒裂解疫苗(安尔来福®)和四价流感病毒裂解疫苗、水痘减毒活疫苗、腮腺炎减毒活疫苗、23价肺炎球菌多糖疫苗、Sabin株脊髓灰质炎灭活疫苗等。其中,甲型肝炎灭活疫苗孩尔来福®、Sabin株脊髓灰质炎灭活疫苗以及水痘减毒活疫苗已先后通过WHO预认证;新型冠状病毒灭活疫苗克尔来福®已列入世界卫生组织(WHO)紧急使用清单,并在包括中国在内的60余个国家和地区获批使用。助力全球抗击新冠疫情,SINOVAC科兴获评第二届中国品牌强国盛典“年度特别贡献品牌”。截至目前,SINOVAC科兴共有4款疫苗获得WHO资格认证,是国内唯一一家旗下所有疫苗生产企业皆拥有WHO资格认证产品的疫苗公司。 科兴控股生物技术有限公司(Sinovac Biotech Ltd.,SINOVAC科兴)是一家总部位于北京的生物高新技术企业,目前在美国纳斯达克全球精选市场(Nasdaq-GS:SVA)上市。公司通过全资子公司科兴控股香港有限公

Basic Information

Documented Facts

Products and Services

Evidence and Sources

Citation Guidance

Explore Healthcare profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Sinovac Biotech.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Sinovac Biotech is listed in Healthcare with headquarters or operating location listed as Beijing, China on BrandSource.AI.

Available profile information

Known data gaps

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.